Analysts Conflicted on These Healthcare Names: LivaNova PLC (LIVN) and Grifols SA (GRFS)


Analysts have been eager to weigh in on the Healthcare sector with new ratings on LivaNova PLC (LIVN) and Grifols SA (GRFS).

LivaNova PLC (LIVN)

Berenberg Bank analyst Scott Bardo maintained a Buy rating on LivaNova PLC yesterday and set a price target of $114.00. The company’s shares closed last Monday at $74.55, close to its 52-week low of $64.80.

According to TipRanks.com, Bardo is a 4-star analyst with an average return of 11.2% and a 60.0% success rate. Bardo covers the Healthcare sector, focusing on stocks such as Siemens Healthineers AG, Tecan Group AG, and Qiagen NV.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for LivaNova PLC with a $98.33 average price target.

See today’s analyst top recommended stocks >>

Grifols SA (GRFS)

Grifols SA received a Hold rating and a EUR29.70 price target from Berenberg Bank analyst Tom Jones yesterday. The company’s shares closed last Monday at $20.69.

According to TipRanks.com, Jones is ranked #4978 out of 5575 analysts.

The word on The Street in general, suggests a Hold analyst consensus rating for Grifols SA with a $26.82 average price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts